FDA Drug Application (019441) for NOVOLIN 70/30 by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number019441
Product Number001
FormINJECTABLE;INJECTION
Dosage30 UNITS/ML;70 UNITS/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVOLIN 70/30
Active IngredientINSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN

Active IngredientCount
List of drugs with Active Ingredient INSULIN RECOMBINANT HUMAN11
List of drugs with Active Ingredient INSULIN RECOMBINANT PURIFIED HUMAN4
List of drugs with Active Ingredient INSULIN SUSP ISOPHANE RECOMBINANT HUMAN6
List of drugs with Active Ingredient INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN4


Back to FDA Applications sponsored by NOVO NORDISK INC